iNOs-IN-1

• CAT Number: I043974
• Molecular Formula: C25H28N4O5
• Molecular Weight: 464.51
• Purity: ≥95%
• Synonyms: (2S)-3-(3a,7a-dihydro-1H-indol-3-yl)-2-[[(2S)-1-[(2R)-2-amino-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carbonyl]amino]propanoic acid
• InChI: InChI=1S/C25H30N4O5/c26-19(12-15-7-9-17(30)10-8-15)24(32)29-11-3-6-22(29)23(31)28-21(25(33)34)13-16-14-27-20-5-2-1-4-18(16)20/h1-2,4-5,7-10,14,18-22,27,30H,3,6,11-13,26H2,(H,28,31)(H,33,34)/t18?,19-,20?,21+,22+/m1/s1
• InChIKey: QFQRIUSUXVQVLV-WHVLVZFFSA-N
• SMILES: C1C[C@H](N(C1)C(=O)[C@@H](CC2=CC=C(C=C2)O)N)C(=O)N[C@@H](CC3=CNC4C3C=CC=C4)C(=O)O

iNOs-IN-1（Cat No.:I043974）is a selective small-molecule inhibitor designed to target inducible nitric oxide synthase (iNOS), an enzyme responsible for the production of nitric oxide (NO) in response to inflammatory stimuli. iNOS plays a crucial role in inflammation, immune response, and various pathological conditions such as sepsis, cancer, and neurodegenerative diseases. By inhibiting iNOS activity, iNOs-IN-1 aims to reduce excessive NO production, mitigating inflammation and tissue damage. This compound shows potential as a therapeutic agent for treating inflammatory diseases, autoimmune disorders, and cancers where iNOS is upregulated.